Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: Comparison with non-injecting drug users

Asian Journal of Psychiatry

Volumn 6, Issue 1, 2013, Pages 52-55

  Basu, Debasish ^a   Kumar, Vineet ^a   Sharma, Arun Kumar ^a   Barnwal, Pawan Kumar ^a   Mattoo, Surendra Kumar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hepatitis C virus (HCV); Injecting drug use; Risk behaviour

Indexed keywords

BUPRENORPHINE; DIAZEPAM; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; PROMETHAZINE;

ADULT; ANTIBODY SCREENING; ARTICLE; BLOOD TRANSFUSION; HEPATITIS C; HIGH RISK BEHAVIOR; HOSPITAL PATIENT; HUMAN; INDIA; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSTITUTION; SEROPREVALENCE; SEXUAL BEHAVIOR; TERTIARY HEALTH CARE; UNSAFE SEX;

ADULT; BLOOD TRANSFUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS C ANTIBODIES; HUMANS; INDIA; MALE; NEEDLE SHARING; RISK FACTORS; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; UNSAFE SEX;

EID: 84873127320     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2012.08.008     Document Type: Article

References (14)

1. Basu D. Overview of substance abuse and hepatitis C virus infection and co-infections in India. Journal of Neuroimmune Pharmacology 2010, 5(4):496-506.
2. Baveja U.K., Chattopadhya D., Khera R., Joshi P.M. A cross sectional serological study of the co-infection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi. Indian Journal of Medical Microbiology 2003, 21(4):280-283.
3. Chelleng P.K., Borkakoty B.J., Chetia M., Das H.K., Mahanta J. Risk of hepatitis C infection among injection drug users in Mizoram, India. Indian Journal of Medical Research 2008, 128(5):640-646.
4. Devi K.S., Brajachand N., Singh H.L., Singh Y.M. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. Journal of Communicable Diseases 2005, 37(1):73-77.
5. Devi K.S., Singh N.B., Mara J., Singh T.B., Singh Y.M. Seroprevalence of hepatitis B virus and hepatitis C virus among hepatic disorders and injecting drug users in Manipur - a preliminary report. Indian Journal of Medical Microbiology 2004, 22(2):136-137.
6. Jindal N., Arora U., Singh K. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India. Japanese Journal of Infectious Diseases 2008, 61(1):79-81.
7. Mahanta J., Borkakoty B., Das H.K., Chelleng P.K. The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care 2009, 21(11):1420-1424.
8. Neaigus A., Gyarmathy V.A., Zhao M., Miller M., Friedman S.R., Des Jarlais D.C. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. Journal of Infectious Diseases 2007, 195(7):1052-1061.
9. Sandesh K., Varghese T., Harikumar R., Beena P., Sasidharan V.P., Bindu C.S., Tony J., Harish K., Sunilkumar K., Ramachandran T.M. Prevalence of hepatitis Band C in the normal population and high risk groups in north Kerala. Tropical Gastroenterology 2006, 27(2):80-83.
10. Saraswathi K., Dutta A. Study of human immunodeficiency virus and HCV infections in intravenous drug users in Mumbai. Indian Journal of Medical Microbiology 2007, 25(2):174-175.
11. Sarkar K., Bal B., Mukherjee R., Chakraborty S., Niyogi S.K., Saha M.K., Bhattacharya S.K. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, bordering Nepal, Bhutan, and Bangladesh. Substance Use and Misuse 2006, 41(3):341-352.
12. Sarkar K., Mitra S., Bal B., Chakraborty S., Bhattacharya S.K. Rapid spread of hepatitis C and needle exchange programme in Kolkata, India. Lancet 2003, 361(9365):1301-1302.
13. Solomon S.S., Srikrishnan A.K., Mehta S.H., Vasudevan C.K., Murugavel K.G., Thamburaj E., Anand S., Kumar M.S., Latkin C., Solomon S., Celentano D.D. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. Journal of Acquired Immune Deficiency Syndromes 2008, 49(3):327-332.
14. Tiwari R., Aggarwal A., Devi P. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses amongst drug users in Amritsar. Indian Journal of Medical Microbiology 2006, 24(2):152-153.